Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2000;87:189-194

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ventura, C.
Right arrow Articles by Maioli, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ventura, C.
Right arrow Articles by Maioli, M.
Related Collections
Right arrow Gene expression
Right arrow Myogenesis
Right arrow Cardiac development
(Circulation Research. 2000;87:189.)
© 2000 American Heart Association, Inc.


Molecular Medicine

Opioid Peptide Gene Expression Primes Cardiogenesis in Embryonal Pluripotent Stem Cells

Carlo Ventura, Margherita Maioli

From the Department of Biomedical Sciences, Division of Biochemistry, Laboratory of Cardiovascular Research, University of Sassari, Sassari, Italy, and National Laboratory of the National Institute of Biostructures and Biosystems, Osilo, Italy.

Correspondence to Carlo Ventura, MD, PhD, Department of Biomedical Sciences, Division of Biochemistry, University of Sassari, Viale San Pietro 43/B, 07100 Sassari, Italy. E-mail chim_med{at}ssmain.uniss.it

Abstract—Zinc finger–containing transcription factor GATA-4 and homeodomain Nkx-2.5 govern crucial developmental fates and have been found to promote cardiogenesis in embryonic cells exposed to the differentiating agent DMSO. Nevertheless, intracellular activators of these transcription factors are largely unknown. In this study, pluripotent P19 cells expressed the prodynorphin gene, an opioid gene encoding for the dynorphin family of opioid peptides. P19 cells were also able to synthesize and secrete dynorphin B, a biologically active end product of the prodynorphin gene. DMSO-primed GATA-4 and Nkx-2.5 gene expression was preceded by a marked increase in prodynorphin gene expression and dynorphin B synthesis and secretion. The DMSO effect occurred at the transcriptional level. In the absence of DMSO, dynorphin B triggered GATA-4 and Nkx-2.5 gene expression and led to the appearance of both {alpha}-myosin heavy chain and myosin light chain-2V transcripts, two markers of cardiac differentiation. Moreover, dynorphin B–exposed cells were positively stained in the presence of MF 20, a mouse monoclonal antibody raised against the {alpha}-myosin heavy chain. Opioid receptor antagonism and inhibition of opioid gene expression by a prodynorphin antisense phosphorothioate oligonucleotide blocked DMSO-induced cardiogenesis, suggesting an autocrine role of an opioid gene in developmental decisions.


Key Words: opioid gene expression • myocardial development • transcription factors • stem cells




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. N. Re and J. L. Cook
The physiological basis of intracrine stem cell regulation
Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H447 - H453.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Cadet, K. J. Mantione, W. Zhu, R. M. Kream, M. Sheehan, and G. B. Stefano
A Functionally Coupled {micro}3-Like Opiate Receptor/Nitric Oxide Regulatory Pathway in Human Multi-Lineage Progenitor Cells
J. Immunol., November 1, 2007; 179(9): 5839 - 5844.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
T. Oyama, T. Nagai, H. Wada, A. T. Naito, K. Matsuura, K. Iwanaga, T. Takahashi, M. Goto, Y. Mikami, N. Yasuda, et al.
Cardiac side population cells have a potential to migrate and differentiate into cardiomyocytes in vitro and in vivo
J. Cell Biol., January 29, 2007; 176(3): 329 - 341.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Kim, A. L. Clark, A. Kiss, J. W. Hahn, R. Wesselschmidt, C. J. Coscia, and M. M. Belcheva
{micro}- and {kappa}-Opioids Induce the Differentiation of Embryonic Stem Cells to Neural Progenitors
J. Biol. Chem., November 3, 2006; 281(44): 33749 - 33760.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Ding, C.-j. Liu, Y. Huang, R. P. Hickey, J. Yu, W. Kong, and P. Lengyel
p204 Is Required for the Differentiation of P19 Murine Embryonal Carcinoma Cells to Beating Cardiac Myocytes: ITS EXPRESSION IS ACTIVATED BY THE CARDIAC GATA4, NKX2.5, AND TBX5 PROTEINS
J. Biol. Chem., May 26, 2006; 281(21): 14882 - 14892.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. Fukuda and S. Yuasa
Stem Cells as a Source of Regenerative Cardiomyocytes
Circ. Res., April 28, 2006; 98(8): 1002 - 1013.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Hakuno, T. Takahashi, J. Lammerding, and R. T. Lee
Focal Adhesion Kinase Signaling Regulates Cardiogenesis of Embryonic Stem Cells
J. Biol. Chem., November 25, 2005; 280(47): 39534 - 39544.
[Abstract] [Full Text] [PDF]


Home page
Evid Based Complement Alternat MedHome page
C. Ventura
CAM and Cell Fate Targeting: Molecular and Energetic Insights into Cell Growth and Differentiation
Evid. Based Complement. Altern. Med., September 1, 2005; 2(3): 277 - 283.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Pepe, O. W.V van den Brink, E. G Lakatta, and R.-P. Xiao
Cross-talk of opioid peptide receptor and {beta}-adrenergic receptor signalling in the heart
Cardiovasc Res, August 15, 2004; 63(3): 414 - 422.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Ventura, M. Maioli, Y. Asara, D. Santoni, I. Scarlata, S. Cantoni, and A. Perbellini
Butyric and Retinoic Mixed Ester of Hyaluronan: A NOVEL DIFFERENTIATING GLYCOCONJUGATE AFFORDING A HIGH THROUGHPUT OF CARDIOGENESIS IN EMBRYONIC STEM CELLS
J. Biol. Chem., May 28, 2004; 279(22): 23574 - 23579.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
B. C. Heng, H. K. Haider, E. K.-W. Sim, T. Cao, and S. C. Ng
Strategies for directing the differentiation of stem cells into the cardiomyogenic lineage in vitro
Cardiovasc Res, April 1, 2004; 62(1): 34 - 42.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. J. Solloway and R. P. Harvey
Molecular pathways in myocardial development: a stem cell perspective
Cardiovasc Res, May 1, 2003; 58(2): 264 - 277.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Sachinidis, B. K. Fleischmann, E. Kolossov, M. Wartenberg, H. Sauer, and J. Hescheler
Cardiac specific differentiation of mouse embryonic stem cells
Cardiovasc Res, May 1, 2003; 58(2): 278 - 291.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. Ventura, E. Zinellu, E. Maninchedda, M. Fadda, and M. Maioli
Protein Kinase C Signaling Transduces Endorphin-Primed Cardiogenesis in GTR1 Embryonic Stem Cells
Circ. Res., April 4, 2003; 92(6): 617 - 622.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. Ventura, E. Zinellu, E. Maninchedda, and M. Maioli
Dynorphin B Is an Agonist of Nuclear Opioid Receptors Coupling Nuclear Protein Kinase C Activation to the Transcription of Cardiogenic Genes in GTR1 Embryonic Stem Cells
Circ. Res., April 4, 2003; 92(6): 623 - 629.
[Abstract] [Full Text] [PDF]